Insider: Ludwig Jeffrey Jerome Chief Commercial Officer - PUMA BIOTECHNOLOGY, INC.
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 108,951 | 0 | 108,951 |
| Value | $527,322.84 | $0.00 | $527,322.84 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 01/02/2025 | DDS | 9,437 | Direct | COM | $3.15 | $29,742.59 | 108,951 |
| 07/02/2024 | DDS | 6,051 | Direct | COM | $3.27 | $19,777.69 | 120,986 |
| 01/03/2023 | DDS | 6,568 | Direct | COM | $4.18 | $27,440.45 | 58,057 |
| 07/05/2022 | DDS | 5,835 | Direct | COM | $2.63 | $15,354.80 | 64,625 |
| 01/03/2022 | DDS | 4,727 | Direct | COM | $3.20 | $15,121.20 | 31,342 |
| 1 You are at page 1 of 1 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research